U.S. Remote Patient Monitoring and Care Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

U.S. Remote Patient Monitoring and Care Market Size

• The U.S. remote patient monitoring and care market size was valued at USD 3.63 billion in 2024 and is expected to reach USD 32.34 billion by 2032, at a CAGR of 31.4% during the forecast period
• The market expansion is primarily driven by the increasing prevalence of chronic diseases, an aging population, and the growing need for cost-effective healthcare delivery solutions outside traditional clinical settings
• Moreover, technological advancements in wearable sensors, mobile health apps, and telehealth integration are enhancing patient engagement and clinician oversight, reinforcing remote monitoring as a vital component of modern healthcare. These evolving dynamics are accelerating market adoption and significantly contributing to sustained growth

U.S. Remote Patient Monitoring and Care Market Analysis

• Remote patient monitoring (RPM) solutions, enabling the electronic tracking of patient health data outside traditional clinical settings, are becoming essential tools in the U.S. healthcare landscape due to their ability to enhance chronic disease management, improve care coordination, and reduce hospital readmissions
• The rising demand for RPM is primarily driven by the growing aging population, increasing burden of chronic illnesses such as diabetes and cardiovascular conditions, and a systemic shift toward value-based care and home-based health services
• In 2024, the U.S. remote patient monitoring and care market experienced robust growth, supported by favorable reimbursement frameworks, high healthcare expenditure, and rapid adoption of digital health technologies, with hospitals and home healthcare providers integrating RPM to expand care delivery and improve patient outcomes
• Telehealth integration and advancements in wearable health devices are expected to further accelerate RPM adoption in the coming years, offering real-time monitoring and data-driven decision-making for both acute and long-term care
• Device segment dominated the U.S. remote patient monitoring and care market with a market share of 48.3% in 2024, driven by its widespread use in tracking vital signs and managing chronic conditions through wearable and connected health technologies

Report Scope and U.S. Remote Patient Monitoring and Care Market Segmentation

U.S. Remote Patient Monitoring and Care Market Trends

“AI-Driven Insights and Integration with Digital Health Ecosystems”

• A prominent and accelerating trend in the U.S. remote patient monitoring (RPM) and care market is the growing integration of artificial intelligence (AI) and connectivity with digital health platforms such as electronic health records (EHRs), telehealth solutions, and patient engagement apps. This synergy is enhancing clinical decision-making, real-time intervention, and personalized care management
• For instance, BioIntelliSense’s BioSticker leverages AI-powered analytics to detect early signs of deterioration by continuously monitoring vital signs and transmitting data to clinicians via cloud-based platforms. Similarly, companies such as Omada Health use AI algorithms to guide chronic disease management programs through remote coaching and real-time health data interpretation
• AI integration enables predictive analytics, flagging potential complications before they escalate and improving patient stratification for targeted care. Some systems, such as Current Health, integrate AI to automate alerts based on patient vitals and activity, helping healthcare providers prioritize interventions effectively
• The integration of RPM tools into broader digital health ecosystems also supports seamless workflows and comprehensive patient monitoring, allowing clinicians to view remote monitoring data alongside other medical records within a single interface, thereby improving continuity of care and clinical efficiency
• This trend toward intelligent, proactive, and integrated care delivery models is fundamentally reshaping the landscape of home-based care. Consequently, companies such as Withings and Philips are expanding their RPM offerings with AI-enhanced dashboards and interoperable platforms that support both patient-facing apps and provider interfaces
• The demand for smart, AI-enabled RPM systems is growing rapidly in the U.S., as healthcare providers seek scalable solutions that enhance outcomes, reduce readmissions, and align with value-based care objectives

U.S. Remote Patient Monitoring and Care Market Dynamics

Driver

“Expanding Need Due to Chronic Disease Burden and Home-Based Care Models”

• The increasing prevalence of chronic diseases such as diabetes, hypertension, and heart failure, along with rising healthcare costs, is a major driver fueling the demand for remote patient monitoring and care solutions in the U.S.
• For instance, in January 2024, Medtronic announced enhancements to its Guardian Connect system, integrating real-time glucose monitoring and coaching features aimed at improving diabetes self-management remotely. Such innovations are expanding the use of RPM in long-term chronic care management
• As the U.S. healthcare system shifts toward decentralized and patient-centered care, RPM offers a scalable and cost-effective solution to manage high-risk patients outside of traditional settings. Features such as continuous monitoring, early warnings, and clinician alerts enhance care quality while reducing unnecessary hospital visits
• Furthermore, supportive policies from CMS and commercial payers, including reimbursement for remote monitoring services, are accelerating adoption across providers. The integration of RPM into value-based care models ensures that outcomes and efficiency remain top priorities
• The convenience of monitoring patients at home, reduced burden on hospital infrastructure, and ability to personalize care plans through mobile health apps are key factors driving RPM expansion. The ongoing evolution of hybrid care models also favors the integration of RPM as a foundational element of modern care delivery

Restraint/Challenge

“Data Privacy Concerns and Regulatory Complexity”

• Despite strong growth potential, concerns around data privacy, cybersecurity, and evolving regulatory requirements pose significant challenges to the widespread adoption of RPM technologies in the U.S.
• Incidents of data breaches and unauthorized access to health information have raised alarms about the safe handling of sensitive patient data transmitted through connected devices and cloud platforms
• For instance, security researchers in late 2023 uncovered vulnerabilities in certain consumer-grade RPM devices that could be exploited to intercept or manipulate health data, emphasizing the need for stringent data protection protocols
• Ensuring compliance with HIPAA, FDA regulations, and interoperability standards such as HL7 and FHIR increases the burden on technology developers and providers. Lack of standardized data-sharing frameworks can further hinder seamless integration across healthcare systems
• Additionally, the cost of implementing robust cybersecurity measures and achieving regulatory clearance may be prohibitive for smaller players. Although larger companies such as Abbott and GE HealthCare have invested in secure, FDA-cleared platforms, navigating compliance remains a barrier to rapid innovation
• Overcoming these challenges through policy clarity, enhanced data encryption, stakeholder education, and cross-platform standardization will be essential to secure long-term trust and adoption of RPM technologies

U.S. Remote Patient Monitoring and Care Market Scope

The market is segmented on the basis of product, application, end user, and distribution channel

• By Product

On the basis of product, the U.S. remote patient monitoring and care market is segmented into devices, mobile apps, hospital-side software, and cloud repositories. The device segment dominated the market with the largest revenue share of 48.3% in 2024, driven by widespread adoption of wearable technologies and home-use medical monitoring devices such as glucose meters, ECG patches, and blood pressure monitors. These devices play a crucial role in tracking real-time patient health metrics, particularly for chronic disease management and post-acute care. The segment also benefits from advances in sensor miniaturization and wireless connectivity.

The mobile apps segment is expected to witness the fastest growth rate from 2025 to 2032, supported by the growing popularity of smartphone-based health management, integration with telehealth services, and increased patient engagement. Mobile apps allow seamless synchronization of patient data, remote consultation, medication reminders, and AI-driven health insights, which are increasingly being adopted in chronic care and preventive health programs.

• By Application

On the basis of application, the U.S. remote patient monitoring and care market is segmented into cardiovascular diseases, diabetes, chronic respiratory diseases, sleep disorder, cancer, dementia and fall, infertility, weight management and fitness monitoring, dehydration, bronchitis, oncology, infections, hypertension, COVID-19, and others. The cardiovascular diseases segment held the largest market revenue share of 28.6% in 2024, due to the high prevalence of heart-related conditions in the U.S. and the critical need for continuous monitoring of heart rate, blood pressure, and ECG through remote technologies. Early intervention and improved patient outcomes are key factors driving adoption in this category.

The diabetes segment is projected to register the fastest growth rate from 2025 to 2032, driven by increased usage of continuous glucose monitors (CGMs) and mobile-integrated insulin management systems. The growing diabetic population and shift toward self-management tools are enhancing the appeal of RPM in this application.

• By End User

On the basis of end user, the U.S. remote patient monitoring and care market is segmented into providers, payers, patients, and others. The providers segment dominated the U.S. market with the largest share of 52.3% in 2024, owing to widespread adoption of RPM by hospitals, clinics, and home healthcare agencies to manage patient care remotely and reduce in-person visits. The use of RPM helps healthcare providers improve efficiency, maintain continuity of care, and meet the demands of value-based care models.

The payers segment is expected to experience the fastest growth from 2025 to 2032, as insurance companies increasingly recognize the cost-saving benefits of RPM. Expanding reimbursement policies and payer-driven chronic care management initiatives are encouraging broader deployment of remote monitoring technologies.

• By Distribution Channel

On the basis of distribution channel, the U.S. remote patient monitoring and care market is segmented into direct sales, retail sales, and others. The direct sales segment held the dominant market revenue share of 54.1% in 2024, as large healthcare systems and providers prefer direct procurement of RPM devices and platforms to customize integration and ensure compatibility with their internal systems. This channel also offers bulk purchasing advantages and technical support.

The retail sales segment is projected to grow at the fastest CAGR from 2025 to 2032, supported by increased consumer awareness, availability of affordable over-the-counter health monitoring devices, and rising demand for self-monitoring tools by health-conscious individuals.

U.S. Remote Patient Monitoring and Care Market Share

The U.S. remote patient monitoring and care industry is primarily led by well-established companies, including:

• Medtronic (U.S.)
• Abbott (U.S.)
• GE HealthCare (U.S.)
• Philips North America (U.S.)
• Dexcom, Inc. (U.S.)
• ResMed (U.S.)
• Masimo (U.S.)
• Withings Health Solutions (U.S.)
• BioIntelliSense, Inc. (U.S.)
• AliveCor, Inc. (U.S.)
• iRhythm Technologies, Inc. (U.S.)
• CareSimple Inc. (U.S.)
• AMC Health (U.S.)
• Health Recovery Solutions (U.S.)
• Tytocare Inc. (U.S.)
• Vivify Health, Inc. (U.S.)
• Vivalink, Inc. (U.S.)
• Glooko, Inc. (U.S.)

What are the Recent Developments in U.S. Remote Patient Monitoring and Care Market?

• In April 2024, Medtronic plc launched an enhanced version of its Guardian Connect system in the U.S., integrating real-time continuous glucose monitoring (CGM) with predictive alerts and remote coaching features. This advancement is aimed at improving diabetes management through proactive insights and clinician-patient connectivity. The launch reaffirms Medtronic’s position in the RPM space by offering more personalized and data-driven care solutions for chronic disease management
• In March 2024, Philips announced a collaboration with the Veterans Health Administration (VHA) to expand its telehealth and remote monitoring capabilities for veterans with chronic conditions. The initiative includes wearable biosensors and AI-based analytics to monitor vital signs and facilitate early intervention. This partnership highlights Philips’ strategic focus on scaling RPM for large populations and enhancing care delivery across the U.S. healthcare system
• In March 2024, BioIntelliSense partnered with UCHealth in Colorado to deploy its BioButton wearable for post-discharge remote monitoring of surgical patients. The device enables continuous tracking of temperature, heart rate, and respiratory rate, allowing clinicians to intervene early in case of complications. This rollout illustrates the growing demand for RPM in transitional care and the company’s commitment to improving outcomes through real-time, wearable-enabled insights
• In February 2024, Withings Health Solutions launched U.S. distribution of its Body Pro 2, a connected smart scale integrated with cellular connectivity and remote data sharing capabilities. Designed for chronic care programs and remote coaching, the device offers clinicians real-time access to patient weight trends and behavior patterns. The innovation underscores Withings’ approach to making clinical-grade remote monitoring tools accessible in both home and primary care settings
• In January 2024, Current Health, a Best Buy Health company, introduced expanded integration features for its RPM platform, allowing seamless connectivity with more third-party devices and EHR systems. The update enhances clinician workflows and supports multi-condition monitoring from a unified dashboard. This development reflects Current Health’s strategy to strengthen interoperability and drive holistic, remote-first care solutions across diverse healthcare providers in the U.S.

SKU-63316